Table 2 |
|||||
|
Day 28 failure rates estimated by four methods – AS+AQ treatment |
|||||
Day 28 failure rates % [CI95%] |
|||||
|
|
|||||
| Year |
Country & Site |
Method 1a (per protocol) |
Method 1b |
Method 2a (WHO 2001) |
Method 2b |
|
|
|||||
| 2003 |
Angola, Kuito |
1.3 |
1.2 |
1.2 |
1.2 |
| [0–6.8] |
[0–6.4] |
[0.2–8.3] |
[0.2–8.1] |
||
| 2003 |
DRC, Boende |
18.3 |
14.1 |
15.3 |
56.3 |
| [9.5–30.4] |
[7.2–23.8] |
[8.7–25.9] |
[45.8–67.4] |
||
| 2003 |
S Sudan, Nuba |
7.3 |
5.6 |
6.2 |
8.4 |
| [2.0–17.6] |
[1.5–12.6] |
[2.4–15.7] |
[3.9–18.0] |
||
| 2003 |
Uganda, Amudat |
22.6 |
8.8 |
10.4 |
21.4 |
| [9.6–41.1] |
[3.6–17.2] |
[4.9–21.1] |
[14.0–31.8] |
||
| 2003 |
Uganda, Jinja |
7.9 |
6.5 |
7.0 |
12.2 |
| [3.2–15.7] |
[2.7–13.0] |
[3.4–14.1] |
[7.2–20.1] |
||
| 2003 |
Uganda, Kampala |
4.9 |
4.1 |
4.3 |
4.3 |
| [1.0–13.7] |
[0.9–11.5] |
[1.4–12.8] |
[1.4–12.9] |
||
| 2004 |
Angola, Caala |
0 |
0 |
0 |
1.5 |
| [0–6.0]* |
[0–5.7]* |
[0–5.8]* |
[0.2–10.4] |
||
| 2004 |
Congo, Kindamba |
6.0 |
4.8 |
4.8 |
6.4 |
| [1.6–14.6] |
[1.3–11.9] |
[1.8–12.2] |
[2.9–13.7] |
||
| 2004 |
DRC, Kabalo |
0 |
0 |
0 |
4.4 |
| [0–8.4]* |
[0–7.9]* |
[0–7.9]* |
[1.1–16.3] |
||
| 2004 |
Guinea, Dabola |
1.0 |
0.9 |
0.9 |
0.9 |
| [0–5.3] |
[0–5.1] |
[0.1–6.5] |
[0.1–6.5] |
||
| 2004 |
S Leone, Kailahun |
27.0 |
15.4 |
19.0 |
20.5 |
| [16.6–39.6] |
[9.3–23.6] |
[12.3–28.8] |
[13.5–30.5] |
||
| 2004 |
Uganda, Apac |
24.5 |
15.0 |
15.7 |
15.9 |
| [16.2–34.4] |
[9.8–21.7] |
[10.7–22.7] |
[10.8–23.1] |
||
| 2004 |
Uganda, Arua |
28.7 |
19.9 |
20.0 |
20.0 |
| [20.4–38.2] |
[13.9–27.0] |
[14.5–27.2] |
[14.6–27.0] |
||
| 2004 |
Uganda, Tororo |
39.3 |
14.5 |
17.8 |
20.0 |
| [27.1–52.7] |
[9.5–20.9] |
[12.1–25.8] |
[13.6–28.9] |
||
| 2005 |
Uganda, Tororo |
13.9 |
5.5 |
5.4 |
5.9 |
| [6.9–24.1] |
[2.6–9.8] |
[2.9–9.8] |
[3.3–10.4] |
||
|
|
|||||
|
*one-sided 97.5% CIs |
|||||
|
Ashley et al. Malaria Journal 2008 7:154 doi:10.1186/1475-2875-7-154 |
|||||